BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 29, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 16, 1998
View Archived Issues
Seattle Genetics initiates a phase I clinical trial of SGN-10
Read More
Phase II trials of Xenova's P-gp pump inhibitor planned in U.S. and U.K.
Read More
Vanguard drops hyperphosphatemia Rx from development pipeline
Read More
MedImmune and BioTransplant initiate two new clinical studies of MEDI-507
Read More
Merck KGaA prefers alliances to mergers; signs new deal with ImClone Systems
Read More
Neoprobe to develop product for intraoperative detection of neuroblastoma
Read More
FDA grants expedited development status to Cordox as it begins phase III trials
Read More
TerraGen and Schering-Plough Research Institute establish collaborative agreement
Read More
SmithKline Beecham and Ribi announce positive HBV phase III trial data
Read More
Dendreon presents phase I/II data on APC-8020 at ASH meeting
Read More
Eisai launches new formulation of antiarrhythmic drug in Japan
Read More
SonoRx studies presented at RSNA meeting; U.S. launch imminent
Read More
AMI-227: a novel contrast agent with several potential uses in MRI
Read More
New RES-specific contrast agents enter the pipeline at Bracco
Read More
News from RSNA 98: German team describes MRI contrast agent CMD-Gd-DOTA
Read More
Elastase inhibition as a potential approach to treating acute viral myocarditis
Read More
Angiotech initiates another clinical trial with paclitaxel for treatment of psoriasis
Read More
Tularik, Knoll to collaborate on antiobesity R&D
Read More
ISS-DNA alters the immune response and prevents symptoms of allergic asthma
Read More
New antidiabetic agents from Yamanouchi have a dual mechanism of action
Read More
PLA2 inhibitors with broad potential application as antiinflammatory agents
Read More
New agents for micturition disorders discovered at Kyowa Hakko
Read More
